AUSTIN (March 26, 2013)—The construction of a $91 million vaccine manufacturing center at Texas A&M University will create thousands of jobs while protecting the country against future biological threats and influenza pandemics, state officials announced Tuesday.
Gov. Rick Perry, A&M System Chancellor John Sharp and others gathered Tuesday morning at the Capitol to discuss the collaboration involving A&M, global pharmaceutical giant GlaxoSmithKline and the federal government.
Details of the manufacturing center were first released in July but the U.S. Department of Health and Human Services recently gave federal approval for the center, which will be built in College Station.
Perry said the facility will anchor a larger development and manufacturing complex that's expected to generate $41 billion in expenditures in the state over the next 25 years.
“Over the past decade, we have invested in innovative programs to prioritize research in our state at both our universities and in the private sector,” Perry said.
“This combined with Texas’ workforce and business climate have made us a leader in high-tech innovation, research, development and commercialization,”Perry said.
“Not only will this center keep Americans safer from epidemic, it will bring in more than $41 billion to the state over the next 25 years and contribute to the creation of more than 6,800 jobs in Texas.”